1. Identification of the von Hippel-Lindau disease tumor suppressor gene;Latif;Science,1993
2. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis;Clifford;Genes Chromosomes Cancer,1998
3. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells;Kourembanas;J Clin Invest,1990
4. Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)(−/−) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis;de Paulsen;Proc Natl Acad Sci USA,2001
5. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship;Mendel;Clin Cancer Res,2003